Use of surrogate endpoints in healthcare policy - Research Database, The University of York

By the same authors

Implementation of coverage with evidence development schemes for medical devices: a decision tool for late technology adopter countries
Drummond, M., Kovacs, S., Kalo, Z., Daubner-Bendes, R., Kolasa, K., Hren, R., Tesar, T., Reckers-Droog, V., Brouwer, W. B. F., Federici, C. & Zemplenyi, A., 23 Mar 2022, (E-pub ahead of print)
Article in Health Economics
Coverage with evidence development for medical devices in Europe: Can practice meet theory?
Drummond, M., Federici, C., Reckers-Droog, V., Torbica, A., Blankart, C. R., Ciani, O., Kalo, Z., Kovacs, S. & Brouwer, W. B. F., 26 Feb 2022, (E-pub ahead of print)
Article in Health Economics
Consideration of quality of life in the health technology assessments of rare disease treatments
Drummond, M., Nicod, E., Meregaglia, M., Whittal, A., Upadhyaya, S. & Facey, K., 29 Oct 2021
Article in European Journal of Health Economics
Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe
Drummond, M., Tunis, S., Hanna, E., Neumann, P. J., Toumi, M., Dabous, O., Fricke, F. U., Sullivan, S. D., Malone, D. C., Persson, U. & Chambers, J. D., 13 Oct 2021, (E-pub ahead of print)
Article in Health Policy
Application of economic evidence in health technology assessment and decision-making for the allocation of health resources in Latin America: Seven key topics and a preliminary proposal for implementation
Drummond, M., Pichon-Riviere, A., Garcia Marti, S. & Augustovski, F., 6 Oct 2021
Article in Inter-American Development Bank report

From the same journal

Twenty years on: the impact of fragments on drug discovery
Erlanson, D. A., Fesik, S. W., Hubbard, R. E., Jahnke, W. & Jhoti, H., Sep 2016
Review article in Nature Reviews Drug Discovery
Biophysics in drug discovery: impact, challenges and opportunities
Renaud, J-P., Chung, C-W., Danielson, U. H., Egner, U., Hennig, M., Hubbard, R. E. & Nar, H., 12 Aug 2016
Review article in Nature reviews. Drug discovery

Use of surrogate endpoints in healthcare policy: proposal for consistent adoption of a validation framework

Research output: Contribution to journal › Letter › peer-review

Full text download(s)

OC MB MD GR ES RT NatureRevDrugDiscovery_Surrogate_final 270416
266 KB, PDF document

Published copy (DOI)

10.1038/nrd.2016.81

Author(s)

O. Ciani
M. Buyse
M.F. Drummond
G. Rasi
E.D. Saad
R.S. Taylor

Department/unit(s)

Centre for Health Economics

Publication details

Journal	Nature Reviews Drug Discovery
Date	Accepted/In press - 26 Apr 2016
Date	Published (current) - 3 Jun 2016
Volume	15
Number of pages	2
Pages (from-to)	1-2
Original language	English

Bibliographical note

© 2016, Nature Publishing Group. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations

York staff: edit these data

The York Research Database

By the same authors

Implementation of coverage with evidence development schemes for medical devices: a decision tool for late technology adopter countries

Coverage with evidence development for medical devices in Europe: Can practice meet theory?

Consideration of quality of life in the health technology assessments of rare disease treatments

Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe

Application of economic evidence in health technology assessment and decision-making for the allocation of health resources in Latin America: Seven key topics and a preliminary proposal for implementation